Sanjivani Parenteral Limited Reports FY26 Full-Year Results; EBITDA stood at Rs 114 mn with PAT at Rs 66.94 mn
Mumbai (Maharashtra) [India], May 15: Sanjivani Paranteral Limited (Sanjivani, The Company) (BSE:531569), one of the emerging players in the pharmaceutical and healthcare manufacturing sector, continued to strengthen its operational performance during the year through improved efficiencies, focused execution, and a customer-centric approach across its business segments, and has announced its Audited Financial Results for Q4 […]
Continue Reading